170415 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines; Chemokines Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1or LDCF-2
Methods for Diagnosing and Treating Vestibular Schwannoma
#2METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#3COMPOSITIONS AND METHODS FOR ANALYSIS, DETECTION, AND TREATMENT OF MULTIPLE SCLEROSIS
#4METHODS OF TREATING, AMELIORATING AND/OR PREVENTING WOUNDS
#5METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#6MARKER OF ALZHEIMER'S DISEASE AND USE THEREOF
#7BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS
#8Methods for Sample Quality Assessment
#9METHOD FOR DETECTING INFLAMMATION-RELATED PLATELET ACTIVATION
#10TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS THERAPEUTIC TARGETS FOR COVID-19
#11METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#12METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#13Biomarkers of fast progression of chronic kidney disease
#14Biomarkers of neutrophil deregulation as diagnostic for gingivitis
#15Methods of Treating an Autoimmune Disease with a Human Interleukin-3 (IL-3)-Diphtheria Toxin Conjugate (DT-IL3)
#16METHOD FOR DIAGNOSING LIVER DISEASES AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR LIVER DISEASES USING CHANGES IN EXPRESSION OF TM4SF5 PROTEIN
#17Biomarkers for graft-versus-host disease
#18METHOD FOR MEASURING SYSTEMIC CHRONIC INFLAMMAGING
#19Urine markers and formula for diagnosing overactive bladder disorder
#20METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#21Peptide Libraries and Methods of Use
#22BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#23Materials and methods for subjects at risk for viral reactivation
#24MATERIAL AND METHODS FOR DIAGNOSING AND TREATING KAWASAKI DISEASE AND KLS
#25PPAR AGONIST OR LXR AGONIST FOR USE IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY MODULATION OF LAP ACTIVITY
#26Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
#27Method for diagnosing and treating fibromyalgia
#28Methods and compositions for treatment of autoimmune hepatitis
#29Future cardiac event biomarkers CCL3, CCL5, and CCL18
#30ASSAY
#31Methods for evaluation of the effectiveness of a drug or drug candidate in treating an inflammatory bowel disease by use of multiplexed assay kit comprising various biomarkers
#32BIOMARKERS OF FAST PROGRESSION OF CHRONIC KIDNEY DISEASE
#33GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES
#34Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast
#35Method for treating muscular dystrophy
#36METHODS FOR DIAGNOSING CELIAC DISEASE USING CIRCULATING CYTOKINES/CHEMOKINES
#37LKB1 related diagnostics and treatments of cancer
#38Persevere-II: redefining the pediatric sepsis biomarker risk model with septic shock phenotype
#39Biomarker and methods for early diagnosis of Alzheimer's disease
#40PROTECTION OF TCR SIGNALING CHAINS IN CANCER PATIENTS AND ENHANCEMENT OF CAR-T CELL THERAPY
#41Kidney disease biomarker
#42BIOMARKERS FOR LOWER URINARY TRACT SYMPTOMS (LUTS)
#43Suppression of cytokine release and cytokine storm
#44Antibody and Cytokine Biomarker Profiling for Determination of Patient Responsiveness
#45Biological markers useful in cancer immunotherapy
#46Carbohydrate Compounds for Nutritional and Therapeutic Use
#47Methods for determining responsiveness to an anti-CD47 agent
#48FUTURE CARDIAC EVENT BIOMARKERS
#49BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOF
#50CCL22 and CCL17 cancer biomarkers
#51NOVEL GROUPS OF BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE
#52HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders
#53SALIVARY BIOASSAY FOR EARLY DETECTION OF BONE LOSS
#54METHODS AND KITS FOR DETECTING ANTIGEN-INDUCED MEMORY CD8+ T CELLS
#55Biomarkers for the identification of liver damage
#56Method for diagnosing fibromyalgia
#57BIOMARKERS FOR OVARIAN CANCER
#58Diagnosis and risk stratification of bladder cancer
#59MATERIAL AND METHODS FOR DIAGNOSING AND TREATING KAWASAKI DISEASE AND KLS
#60GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES
#61BIOMARKERS FOR PREDICTING RESPONSE OF DLBCL TO TREATMENT WITH IBRUTINIB
#62Methods and compositions for diagnosis of inflammatory liver disease
#63ANTIKINE ANTIBODIES THAT BIND TO MULTIPLE CC CHEMOKINES
#64Methods and Compositions for Treating or Diagnosing Melanoma
#65BIOMARKERS FOR LOWER URINARY TRACT SYMPTOMS (LUTS)
#66Multiplexed assay kit to evaluate the efficacy of treatment for inflammatory bowel disease
#67Biomarkers for Tuberculosis and HIV/AIDS
#68METHOD FOR DIAGNOSING AND TREATING FIBROMYALGIA
#69Methods of using biomarkers for predicting the outcome of an immunotherapy against cancer
#70Method and reagent for diagnosis and/or evaluation of progression of graft-versus-host disease
#71Biomarkers of immunotherapy efficacy
#72Biomarkers for systemic lupus erythematosus
#73METHOD AND REAGENT FOR DIAGNOSIS AND/OR EVALUATION OF PROGRESSION OF GRAFT-VERSUS-HOST DISEASE
#74METHOD AND REAGENT FOR DIAGNOSIS AND/OR EVALUATION OF PROGRESSION OF GRAFT-VERSUS-HOST DISEASE
#75HMGB1 and anti-HMGB1 antibodies for the prognostic of neurological disorders
#76RANTES Multiplexed Assay, RANTES Variants Related to Disease, and RANTES Variants Related to Enzymatice Activity
#77Salivary Bioassay for Early Detection of Bone Loss
#78BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO IFNB AND USES THEREOF
#79Obesity Dependent Adipokine Biomarkers for Prostate Cancer
#80RANTES LEVELS AS A DIAGNOSTIC AND THERAPEUTIC FOR ACUTE GRAFT VERSUS HOST DISEASE
#81METHODS FOR MODULATING MACROPHAGE PROLIFERATION IN OCULAR DISEASE USING POLYAMINE ANALOGS
#82BIOMARKERS AND THERAPEUTIC TARGETS FOR TYPE 1 DIABETES
#83Methods of using biomarkers for predicting the outcome of an immunotherapy against cancer
#84Method for detection of active periodontal disease at the local tooth site
#85BIOMARKERS FOR PREDICTING SUSTAINED RESPONSE TO HCV TREATMENT
#86SYSTEMS AND METHODS FOR CHARACTERIZING LUPUS ERYTHEMATOSUS
#87NOVEL GROUPS OF BIOMARKERS FOR DIAGNOSING ALZHEIMER'S DISEASE
#88Endometriosis markers
#89Antikine antibodies that bind to multiple CC chemokines
#90Future cardiac event biomarkers CCL3, CCL5 and CCL18
#91DIAGNOSTIC TEST
#92Biomarkers for Atherosclerosis
#93Method for assessing risk of heart failure
#94Salivary bioassay for early detection of bone loss
#95METHOD FOR DETECTION OR TREATMENT OF GRAFT VERSUS HOST DISEASE
#96GLUTAMINYL CYCLASE AS A DIAGNOSTIC/PROGNOSTIC INDICATOR FOR NEURODEGENERATIVE DISEASES
#97ANTIFIBROTIC THERAPY
#98Method for diagnosing and treating acute joint injury
#99Antibody profiling for determination of patient responsiveness
#100Diagnostic test
#101Methods for modulating macrophage proliferation in ocular disease using polyamine analogs